Latest Publications

Share:

Venture Funding Reaches Highest Level in More Than a Decade

Last month, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its MoneyTree Report on venture funding for 2014. The report, which is...more

2/25/2015 - Biotechnology Funding Life Sciences Software Startups Venture Capital Venture Funding

USPTO Holds Forum on Interim Guidance -- Part III

In a forum held last month on the U.S. Patent and Trademark Office's Alexandria campus, Office representatives discussed the Interim Guidance on Patent Subject Matter Eligibility, which was released in December, and received...more

2/20/2015 - CLS Bank v Alice Corp Covered Business Method Patents Life Sciences Patent-Eligible Subject Matter Patents Technology USPTO

USPTO Holds Forum on Interim Guidance -- Part II

In a forum held last month on the U.S. Patent and Trademark Office's Alexandria campus, Office representatives discussed the Interim Guidance on Patent Subject Matter Eligibility, which was released in December, and received...more

2/19/2015 - Interim Guidance Patent-Eligible Subject Matter Patents Public Comment USPTO

USPTO Holds Forum on Interim Guidance -- Part I

In a forum held January 21 on the U.S. Patent and Trademark Office's Alexandria campus, Office representatives discussed the Interim Guidance on Patent Subject Matter Eligibility, which was released in December, and received...more

2/4/2015 - Interim Guidance Myriad-Mayo Patent-Eligible Subject Matter Patents USPTO

Promega Corp. v. Life Technologies Corp. (Fed. Cir. 2014)

Last month, in Promega Corp. v. Life Technologies Corp., the Federal Circuit determined that U.S. Patent Nos. 5,843,660; 6,221,598; 6,479,235; and 7,008,771, which are owned by Promega Corp., are invalid under 35 U.S.C. §...more

1/14/2015 - IP License Patent Infringement Patent Litigation Patents

Top Three Stories of 2014

After reflecting upon the events of the past twelve months, Patent Docs presents its eighth annual list oftop patent stories. For 2014, we identified eighteen stories that were covered on Patent Docs last year that we...more

1/8/2015 - America Invents Act AMP v Myriad CLS Bank v Alice Corp DNA Genetic Materials Mayo v. Prometheus Patent Litigation Patent-Eligible Subject Matter Patents Post-Grant Review USPTO

Top Stories of 2014: #6 to #4

After reflecting upon the events of the past twelve months, Patent Docs presents its eighth annual list of top patent stories. For 2014, we identified eighteen stories that were covered on Patent Docs last year that we...more

1/7/2015 - DNA Genetic Materials Indefiniteness Induced Infringement Limelight v Akamai Myriad v Ambry Nautilus Inc. v. Biosig Instruments Patent Litigation Patents

Top Stories of 2014: #10 to #7

After reflecting upon the events of the past twelve months, Patent Docs presents its eighth annual list of top patent stories. For 2014, we identified eighteen stories that were covered on Patent Docs last year that we...more

1/5/2015 - America Invents Act BPCIA CLS Bank v Alice Corp FDA Fee-Shifting Highmark v. Allcare Octane Fitness v. ICON Patent Trolls Patents Pharmaceutical Patents Sandoz SCOTUS

Top Stories of 2014: #14 to #11

After reflecting upon the events of the past twelve months, Patent Docs presents its eighth annual list of top patent stories. For 2014, we identified eighteen stories that were covered on Patent Docs last year that we...more

1/2/2015 - AbbVie Claim Construction Gilead Sciences IP License Medtronic Novartis Patent Term Adjustment Patents Pharmaceutical Manufacturers Pharmaceutical Patents SCOTUS Teva v Sandoz

Top Stories of 2014: #15 to #18

After reflecting upon the events of the past twelve months, Patent Docs presents its eighth annual list of top patent stories. For 2014, we identified eighteen stories that were covered on Patent Docs last year that we...more

1/2/2015 - Patent Reform Patents

USPTO News Briefs - December 2014

USPTO Closed on December 26 - The U.S. Patent and Trademark Office issued a notice today informing stakeholders that the Office will be closed on Friday, December 26, 2014. The notice indicated that December 26 will...more

12/23/2014 - Holidays USPTO Websites

USPTO Issues Interim Guidance on Subject Matter Eligibility

Earlier today, the U.S. Patent and Trademark Office published its interim guidance regarding the examination of claims for subject matter eligibility under 35 U.S.C. § 101 (which the Office announced yesterday) in the Federal...more

12/17/2014

USPTO to Release Revised Subject Matter Eligibility Guidance

In a conference call this morning, Drew Hirshfeld, U.S. Patent and Trademark Office Deputy Commissioner for Patent Examination Policy, announced that the USPTO would be releasing revised guidance on subject matter eligibility...more

12/15/2014 - Mayo v. Prometheus Myriad Patent-Eligible Subject Matter Patents USPTO

Examination of Myriad-Mayo Guidance Comments -- The Coalition for 21st Century Medicine -- Part II

On March 4, the U.S. Patent and Trademark Office issued a guidance memorandum, entitled "Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural...more

12/3/2014 - Coalition for 21st Century Medicine Draft Guidance Genetic Materials Mayo v. Prometheus Myriad-Mayo Patent-Eligible Subject Matter Patents USPTO

Examination of Myriad-Mayo Guidance Comments -- The Coalition for 21st Century Medicine

On March 4, the U.S. Patent and Trademark Office issued a guidance memorandum, entitled "Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural...more

12/2/2014 - Draft Guidance Mayo v. Prometheus Myriad-Mayo Patent-Eligible Subject Matter Patents USPTO

USPTO News Briefs - November 2014 #2

Prioritized Examination Interim Rule Adopted As Final - Last March, we reported on an interim rule implemented by the U.S. Patent and Trademark Office that expanded the time periods for meeting certain requirements for...more

11/20/2014 - AFCP Patent Examinations Prioritized Examination QPIDS USPTO

BIO IPCC Panel Discusses Impact of Myriad-Mayo Guidance

Yesterday, we reported on a session of the Biotechnology Industry Organization (BIO) Intellectual Property Counsel's Committee fall conference, which took place earlier this week in Nashville, TN, in which the U.S. Patent and...more

11/14/2014 - Biotechnology Genetic Materials Guidance Update Myriad-Mayo Patent-Eligible Subject Matter Patents Pharmaceutical USPTO

USPTO Provides Update on Status of Revised Myriad-Mayo Guidance

During a session of the Biotechnology Industry Organization (BIO) Intellectual Property Counsels Committee (IPCC) fall conference, which took place this week in Nashville, TN, the U.S. Patent and Trademark Office provided a...more

11/13/2014 - Biotechnology Genetic Materials Guidance Update Myriad-Mayo Patent-Eligible Subject Matter Patents USPTO

USPTO News Briefs - November 2014

ILPO to Act as ISR and IPEA for PCT Applications Received by USPTO - Last month, the U.S. Patent and Trademark Office announced that as of October 1, 2014, the Israel Patent Office (ILPO) can act as an International...more

11/4/2014 - Foreign Patent Applications International Searching Authority Patent Litigation Patents USPTO

Examination of Myriad-Mayo Guidance Comments -- University Community Joint Comment

On March 4, the U.S. Patent and Trademark Office issued a guidance memorandum, entitled "Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural...more

10/29/2014 - Biotechnology Mayo v. Prometheus Myriad Myriad-Mayo Patents Pharmaceutical Patents Universities USPTO

Examination of Myriad-Mayo Guidance Comments -- BIO Joint Comment

On March 4, the U.S. Patent and Trademark Office issued a guidance memorandum, entitled "Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural...more

10/24/2014 - AMP v Myriad Biotechnology Draft Guidance Genetic Materials Mayo v. Prometheus Myriad-Mayo Patent-Eligible Subject Matter Patents Pharmaceutical Manufacturers Public Comment Trade Associations USPTO

Third Quarter Venture Funding Declines 27% from Second Quarter

Last week, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its MoneyTree Report on venture funding for the third quarter of 2014. ...more

10/23/2014 - Entrepreneurs Funding Information Reports Small Business Startups Venture Capital Venture Funding

Sherry Knowles Addresses Real World Impact of Myriad-Mayo Guidance at BIO Symposium

Last month, at the Biotechnology Industry Organization (BIO) IP & Diagnostics Symposium in Alexandria, VA, Sherry Knowles of Knowles IP Strategies addressed the impact of the U.S. Patent and Trademark Office's Myriad-Mayo...more

10/16/2014 - Biotechnology Guidance Update Mayo v. Prometheus Myriad-Mayo Patent-Eligible Subject Matter Patents Pharmaceutical Patents USPTO

USPTO Outlines Changes to Myriad-Mayo Guidance at BIO Symposium

Last Friday, at the Biotechnology Industry Organization (BIO) IP & Diagnostics Symposium in Alexandria, VA, the U.S. Patent and Trademark Office provided additional information regarding changes that the Office plans to make...more

10/1/2014 - AMP v Myriad Guidance Update Mayo v. Prometheus Myriad-Mayo Patent-Eligible Subject Matter Professional Conferences USPTO

Inovia Releases 2014 Report on Global Patent Trends

Patent services provider inovia has released its fifth annual report on global patent and IP trends. In compiling "The 2014 U.S. Global Patent & IP Trends Indicator," inovia, which produces products for PCT national phase...more

9/24/2014 - EU Patent Infringement Patent Litigation Patents Popular USPTO

170 Results
|
View per page
Page: of 7